“In conclusion we have established that there is sufficient supporting evidence for the pre-clinical (experimental) as well as clinical effects of homeopathy, and that in absolute terms, as well as when compared to conventional therapies, it offers a safe and cost-effective treatment.” This is the conclusion of a Health Technology Assessment (HTA) report on the effectiveness, appropriateness, safety and costs of homeopathy in health care.
The report, published under the title “Homeopathy in Europe – Effectiveness, Appropriateness, Safety, Costs”, was commissioned by the Swiss health authorities to inform decision-making on the further inclusion of homeopathy in the list of services covered by statutory health insurance. Other studies carried out as part of the Swiss Complementary Medicine Evaluation Programme (PEK) caused a massive stir due to their schematic and exclusively quantitative (negative-) outcomes for homeopathy. The present report, in contrast, offers a differentiated evaluation of the practice of homeopathy in health care.
It confirms homeopathy as a valuable addition to the conventional medical landscape – a status it has been holding for a long time in practical health care.